Amy Cavers is the VP, Scientific Affairs: Ublituximab/CD20 mAb, Umbralisib (TGR-1202)/PI3K, IRAK4, GITR, PD-L1, BET at Tg Therapeutics Inc based in Phoenix, Arizona, United States.
Amy Cavers
VP, Scientific Affairs: Ublituximab/CD20 mAb, Umbralisib (TGR-1202)/PI3K, IRAK4, GITR, PD-L1, BET at Tg Therapeutics Inc in Phoenix, Arizona, United States
Verified profile
a***@tgtxinc.com
Job Title
VP, Scientific Affairs: Ublituximab/CD20 mAb, Umbralisib (TGR-1202)/PI3K, IRAK4, GITR, PD-L1, BET
Company
Tg Therapeutics Inc
Location
Phoenix, Arizona, United States
Seniority
Vp
Work Email
a***@tgtxinc.com
Amy's full work email still locked
Free account. Verified against live company records.
You'll unlock:
- Amy's full verified work email
- LinkedIn and full company profile
Colleagues at Tg Therapeutics Inc
Other verified contacts at Tg Therapeutics Inc.
Randeep KaurOncology Site Liaison at Tg Therapeutics IncKa-Yin MokClinical Development/Medical Affairs at Tg Therapeutics IncGarrett CliftonManager CMC Drug Substance Operations at Tg Therapeutics IncMichelle' WallaceClinical Research Associate at Tg Therapeutics IncTeja TurpuseemaAssistant Manager, Product Development at Tg Therapeutics IncElisa DownsOncology Clinical Trial Educator at Tg Therapeutics IncLauren DanielAssistant Controller at Tg Therapeutics IncAnnette ForgeySenior CRA at Tg Therapeutics Inc
Frequently asked
What is Amy Cavers's email address?
Amy Cavers's work email follows the pattern a***@tgtxinc.com. Reveal it free.
What does Amy Cavers do?
Amy Cavers is the VP, Scientific Affairs: Ublituximab/CD20 mAb, Umbralisib (TGR-1202)/PI3K, IRAK4, GITR, PD-L1, BET at Tg Therapeutics Inc.
Where is Amy Cavers based?
Phoenix, Arizona, United States.
Who is the VP, Scientific Affairs: Ublituximab/CD20 mAb, Umbralisib (TGR-1202)/PI3K, IRAK4, GITR, PD-L1, BET at Tg Therapeutics Inc?
Amy Cavers.
Get Amy Cavers's verified contact details
Reveal the full work email and more. Free to start.
Try ScraperCity Free →